Overexpression of the gene encoding IGF2 due to LOI/LOH observed in RMS has been implicated in both fetal overgrowth disorders that predispose children to embryonal tumors (including RMS) and RMS tumor cell growth and motility (6, 18, 19). Here, IGF2 is linked to neoplasm.